Heesug CHUNG is a senior foreign attorney (admitted in the State of New York) in the finance and capital markets practice group at Bae, Kim & Lee LLC. His practice covers a broad range of financing and capital markets matters, including corporate financing, overseas investment, foreign-direct investment, acquisition finance, project finance, private equity investment and M&A.
Prior to joining BKL, Mr. Chung worked in the capital markets team at the Hong Kong office of Clifford Chance, where he had advised on some of the largest and most complex capital markets and finance transactions, including IPOs in various jurisdictions such as Hong Kong, Singapore, Malaysia and Korea. After joining BKL, Mr. Chung specializes in capital markets and finance transactions. Particularly in regard to IPO transactions, Mr. Chung advised on large-scale high-profile Korea Exchange listings with international tranches by Korean companies, such as SK Biopharm, Big Hit Entertainment, Samsung Biologics, Doosan Bobcat and Cheil Industries, not to mention complex Korea Exchange listings by foreign companies, such as US companies Psomagen and Englewood Lab, and China-based companies Organic Tea Cosmetics and Great Rich Technologies. In addition, Mr. Chung also advised on major cross-border capital markets transactions by Korean conglomerates, financial institutions, government/quasi-government organizations, including offerings and listings of depositary receipts on foreign exchanges, disclosure updates on foreign exchanges and overseas debt securities/convertible bonds offerings.